Tenet Healthcare (NYSE:THC) CEO Saumya Sutaria Sells 50,000 Shares of Stock

Tenet Healthcare Corporation (NYSE:THC) CEO Saumya Sutaria sold 50,000 shares of Tenet Healthcare stock in a transaction that occurred on Monday, August 24th. The shares were sold at an average price of $278.71, for a total value of $13,935,500.00. Following the sale, the chief executive officer owned 483,564 shares in the company, valued at $134,774,122.44. This represents a 9.37% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Tenet Healthcare Stock Performance

Shares of Tenet Healthcare stock opened at $274.06 on Thursday. Tenet Healthcare Corporation has a 12 month low of $157.58 and a 12 month high of $283.05. The firm has a market capitalization of $22.07 billion, a P/E ratio of 10.57, a P/E/G ratio of 1.04 and a beta of 1.23. The company has a current ratio of 1.41, a quick ratio of 1.35 and a debt-to-equity ratio of 2.00. The business has a fifty day simple moving average of $226.21 and a two-hundred day simple moving average of $208.66.

Tenet Healthcare (NYSE:THC) last announced its quarterly earnings data on Thursday, July 23rd. The company reported $6.12 earnings per share for the quarter, topping analysts’ consensus estimates of $4.26 by $1.86. The business had revenue of $6.04 billion for the quarter, compared to analysts’ expectations of $5.43 billion. Tenet Healthcare had a net margin of 10.27% and a return on equity of 26.76%. The business’s revenue was up 6.8% compared to the same quarter last year. During the same quarter in the prior year, the company earned $4.02 earnings per share. Tenet Healthcare has set its FY 2026 guidance at 20.300-21.690 EPS. On average, equities analysts forecast that Tenet Healthcare Corporation will post 20.98 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Several research firms recently commented on THC. UBS Group lifted their price objective on Tenet Healthcare from $288.00 to $308.00 and gave the stock a “buy” rating in a report on Monday, July 27th. The Goldman Sachs Group reaffirmed a “buy” rating and set a $305.00 price target on shares of Tenet Healthcare in a report on Tuesday, July 28th. Weiss Ratings raised shares of Tenet Healthcare from a “hold (c+)” rating to a “buy (b-)” rating in a report on Thursday, August 20th. Stephens restated an “overweight” rating and issued a $285.00 target price on shares of Tenet Healthcare in a report on Monday, July 27th. Finally, Zacks Research upgraded shares of Tenet Healthcare from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, August 11th. One research analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating and one has assigned a Hold rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Buy” and an average target price of $273.00.

Institutional Investors Weigh In On Tenet Healthcare

Several hedge funds and other institutional investors have recently modified their holdings of the stock. Swedbank AB raised its position in shares of Tenet Healthcare by 14.7% during the fourth quarter. Swedbank AB now owns 146,133 shares of the company’s stock valued at $29,040,000 after buying an additional 18,750 shares during the last quarter. Hsbc Holdings PLC grew its stake in Tenet Healthcare by 3,478.7% during the fourth quarter. Hsbc Holdings PLC now owns 266,400 shares of the company’s stock valued at $53,269,000 after acquiring an additional 258,956 shares in the last quarter. Jackson Creek Investment Advisors LLC increased its holdings in Tenet Healthcare by 235.6% in the 4th quarter. Jackson Creek Investment Advisors LLC now owns 9,032 shares of the company’s stock valued at $1,795,000 after acquiring an additional 6,341 shares during the last quarter. Brandywine Global Investment Management LLC lifted its stake in Tenet Healthcare by 20.5% in the 4th quarter. Brandywine Global Investment Management LLC now owns 126,248 shares of the company’s stock worth $25,088,000 after purchasing an additional 21,435 shares in the last quarter. Finally, Louisiana State Employees Retirement System bought a new position in shares of Tenet Healthcare during the 1st quarter valued at about $4,812,000. 95.44% of the stock is currently owned by hedge funds and other institutional investors.

Tenet Healthcare Company Profile

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.